Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2008-12-12
2010-02-23
Goddard, Laura B (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S004000
Reexamination Certificate
active
07666603
ABSTRACT:
An isolated protein having an amino acid sequence of SEQ ID No. 4 and having an activity inducing apoptosis, and a gene encoding the same are provided. Also, a microarray having a substrate on which the gene or fragment thereof is immobilized is provided. Also, a method of diagnosing breast cancer using an antibody specifically binding to the protein and a method of diagnosing breast cancer by determining whether the gene is expressed in a cell or not, are provided.
REFERENCES:
patent: 7171311 (2007-01-01), Dai et al.
patent: 2002/0086848 (2002-07-01), Kubbies et al.
patent: 2003/0232350 (2003-12-01), Afar et al.
patent: 0008210 (2000-02-01), None
patent: 02086443 (2002-10-01), None
patent: 03003906 (2003-01-01), None
patent: 03042661 (2003-05-01), None
patent: 2004060270 (2004-07-01), None
patent: 2004065545 (2004-08-01), None
De Nooij-Van Dalen, A.G., et al.; “Characterization of the Human LY-6 Antigens, the Newly Annotated Member of LY-6K Included, as Molecular Makers for Head-and-Neck Squamous Cell Carcinoma”; Int. J. Cancer; vol. 103; pp. 768-774; 2003.
NCBI Sequence Viewer; Accession No. NP 059997; p. 1-2; Published Dec. 23, 2003.
European Search Report dated Aug. 26, 2005 for Application No. 05003545.0.
Korean Office Action dated Jun. 30, 2006 for Korean Patent Application No. 10-2005-0009487.
Korean Office Action dated Feb. 26, 2007 for Korean Patent Application No. 10-2005-0009487.
Sequence ID No. 2414 of WO 2004065545, published Aug. 5, 2004.
Orr, et al.; “Disovery of 830 Candidate Therapeutic and Diagnostic Markers for Breast Cancer Using Oligonucleotide Microarray Technology”; Proceedings of the Annual Meeting of the American Association for Cancer Research; New York, NY; vol. 42; p. 124; 2001 (August).
Leerkes, et al.; “In Silico Comparison of the Transcriptome Derived from Purified Normal Breast Cells and Breast Tumor Cell Lines Reveals Candidate Upregulated Genes in Breast Tumor Cells”; Genomics; vol. 79, No. 2; pp. 257-265; Feb. 2002.
Martin, et al.; “A hybridization array assay using differential display-identified markers for early detection and staging of breast cancer”; Proceedings of the Annual Meeting of the American Association for Cancer Research, New York, NY; vol. 40; p. 319; 1999 (October).
Liang, et al.; “Recent advances in differential display”; Current Opinion in Immunology; vol. 7; pp. 274-280;1995.
Watson, et al.; “Isolation of Differentially Expressed Sequence Tags from Human Breast Cancer”; Cancer Research; vol. 54, No. 17; pp. 4598-4602; 1994 (September).
European Office Action dated Mar. 21, 2007 for EP Patent Application No. 05003545.0.
Chinese Office Action dated Sep. 28, 2007 for Chinese Patent Application No. 200510064157.1.
Tockman et al.; “Considerations in Bringing a Cancer Biomarker to Clinical Application”; Cancer Research; (suppl.) 52; pp. 2711s-2718s; 1992.
Greenbaum et al.; “Comparing Protein Abundance and mRNA Expression Levels on a Genomic Scale”; Genome Biology; vol. 4; Issue 9; Article 117; pp. 117.1-117.8; 2003.
Ahn Tae-jin
Lee Yeon-su
Park Jong-hoon
Park Kyung-hee
Cantor & Colburn LLP
Goddard Laura B
Samsung Electronics Co,. Ltd.
LandOfFree
Breast cancer related protein, gene encoding the same, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Breast cancer related protein, gene encoding the same, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Breast cancer related protein, gene encoding the same, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4170820